First Tracks Biotherapeutics, Inc. (TRAX)
NASDAQ: TRAX · Real-Time Price · USD
36.85
+2.38 (6.92%)
Oct 19, 2026, 1:19 PM EDT - Market open
TRAX Stock Forecast
Stock Price Forecast
According to 12 analysts polled by S&P Global, TRAX stock has a consensus rating of "Strong Buy" and an average price target of $74.17. The average 1-year stock price forecast is 101.30% higher than the current stock price, while the lowest is $57 (+54.70%) and the highest is $100 (+171.41%).
Price Target: $74.17 (+101.30%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for TRAX stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 5 | 5 | 6 | 9 | 9 |
| Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 8 | 8 | 9 | 12 | 12 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Leerink Partners | Leerink Partners | Buy Reiterates $70 → $90 | Buy | Reiterates | $70 → $90 | +144.27% | Oct 16, 2026 |
| Wedbush | Wedbush | Buy Maintains $70 | Buy | Maintains | $70 | +89.99% | Oct 13, 2026 |
| J.P. Morgan | J.P. Morgan | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Oct 13, 2026 |
| Evercore ISI | Evercore ISI | Buy Maintains $65 → $70 | Buy | Maintains | $65 → $70 | +89.99% | Oct 13, 2026 |
| Canaccord Genuity | Canaccord Genuity | Buy Reiterates $50 → $60 | Buy | Reiterates | $50 → $60 | +62.84% | Oct 13, 2026 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-4.03
EPS Next Year
-3.62
from -4.03
EPS and Forward PE are based on non-GAAP adjusted numbers.